Valeant Pharmaceuticals is nearing a deal to buy Salix Pharmaceuticals for about $10 billion, in the latest sign the rapid pace of consolidation in the drug industry is set to continue.
from WSJ.com: US Business http://ift.tt/17G10km
via IFTTT
from WSJ.com: US Business http://ift.tt/17G10km
via IFTTT
No comments:
Post a Comment